INSIDERFilingvia Quantisnow
Vivos Therapeutics Inc. logo

Vivos Therapeutics (VVOS) executive Huntsman bought 20,000 shares for $10K at $0.50

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Ronald Kirk Huntsman (executive at Vivos Therapeutics Inc., VVOS) reported that they bought 20,000 shares for $10K at $0.50 on Dec 23, 2022. After these transactions the filing shows 47,500 shares held directly.

Reporting person
Huntsman Ronald Kirk
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Dec 23, 2022Open-market purchase (P)Common Stock1+20,000$0.50$10K47,500 direct

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Dec 23, 2022Grant or award (A)Stock Option (Right to Buy)On 816,668 Common Stock2, 3+483,334avg $0.48$232K483,334 direct

Holdings before and after

  • Common Stock: 27,500 to 47,500 direct
  • Stock Option (Right to Buy): 0 to 483,334 direct

Other positions listed

  • Common Stock: 1,740,000 indirect, See footnote

Footnotes from the filing

  1. 1. Shares held by Coronado V Partners, LLC, of which the reporting person is a member and manager.
  2. 2. 333,334 fully vested stock options granted on December 23, 2022.
  3. 3. 150,000 stock options granted on December 23, 2022. One-fifth vested immediately and one-fifth vests annually on each anniversary date through December 23, 2026.

Transaction codes in this filing

Open-market purchase:
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

FAQ

What did Huntsman report in this VVOS Form 4?

Ronald Kirk Huntsman (executive at Vivos Therapeutics Inc., VVOS) reported that they bought 20,000 shares for $10K at $0.50 on Dec 23, 2022. After these transactions the filing shows 47,500 shares held directly.

How many VVOS shares does Huntsman hold after this filing?

The filing shows 47,500 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code P mean on an SEC Form 4?

Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

Historical context for VVOS

Earlier insider filings at VVOS

Quantisnow market dataNASDAQ
Vivos Therapeutics Inc. logo
VVOS
Vivos Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Medical/Dental Instruments
Listed since
2020
Get push alerts for VVOS

Follow VVOS and get a push notification the moment its next story breaks.

Full VVOS profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VVOS (Vivos Therapeutics Inc.) and more on Quantisnow.